EVALON (Ovestin) 1MG – 30 tablet

EVALON (Ovestin) 1MG – 30 tablet

$7.02

Each Evalon contains 1 mg Estradiol 30 tablets. Evalon is used for Hormone replacement therapy (HRT) for menopausal symptoms

ATC Classification: G03CA04
Active Ingrediant: Estradiol
Generic Name: EVALON
Manufacturer: ORGANON
Strength: 1MG
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 30 Tab

Description

 

Medication Safety Issues

Geriatric Patients: High-Risk Medication:

Beers Criteria: Estrogens (oral or topical patch products only), with or without progestins, are identified in the Beers Criteria as potentially inappropriate medications to be avoided in patients ≥65 years (independent of diagnosis or condition) due to their carcinogenic potential (breast and endometrium) and lack of cardioprotection or cognitive protection in older women. Low-dose intravaginal estrogen (vaginal creams or tablets) are acceptable for dyspareunia, recurrent lower urinary tract infections, and other vaginal symptoms. Of note, women with a history of breast cancer not responding to nonhormonal therapies are advised to discuss the risks/benefits of low-dose vaginal estrogen (estradiol <25 mcg twice weekly) with their health care provider (Beers Criteria [AGS 2019]).

International issues:

Sound-alike/look-alike issues: Estriol may be confused with estradiol, estrone

 

Product Availability (US)

Not available in US

 

Storage/Stability

Store between 15°C to 30°C (60°F to 85°F). Protect from light and moisture.

 

Adverse Reactions

Frequency not defined.

Endocrine & metabolic: Fluid retention, spotty menstruation

Gastrointestinal: Nausea

Genitourinary: Change in cervical secretions, mastalgia

Respiratory: Flu-like symptoms

Brand

ORGANON

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Reviews

There are no reviews yet.

Be the first to review “EVALON (Ovestin) 1MG – 30 tablet”

Your email address will not be published.